Johnson & Johnson (BVMF:JNJB34)

Market Cap	2.24T
Revenue (ttm)	496.48B
Net Income (ttm)	124.14B
Shares Out	n/a
EPS (ttm)	51.13
PE Ratio	18.02
Forward PE	15.31
Dividend	1.27 (2.08%)
Ex-Dividend Date	May 27, 2025

Volume	1,094
Average Volume	3,419
Open	62.56
Previous Close	61.88
Day's Range	61.20 - 62.56
52-Week Range	54.62 - 65.90
Beta	0.40
RSI	61.74
Earnings Date	Jul 16, 2025

About Heartland Financial USA

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: JNJB34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.